{"id":"https://openalex.org/W2048291374","doi":"https://doi.org/10.1016/s0166-3542(00)00070-x","title":"Antiviral activity of ganciclovir elaidic acid ester against herpesviruses","display_name":"Antiviral activity of ganciclovir elaidic acid ester against herpesviruses","publication_year":2000,"publication_date":"2000-03-01","ids":{"openalex":"https://openalex.org/W2048291374","doi":"https://doi.org/10.1016/s0166-3542(00)00070-x","mag":"2048291374","pmid":"https://pubmed.ncbi.nlm.nih.gov/10771080"},"language":"en","primary_location":{"id":"doi:10.1016/s0166-3542(00)00070-x","doi":"https://doi.org/10.1016/s0166-3542(00)00070-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0166-3542(00)00070-x","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030479730","display_name":"Graciela Andre\u00ef","orcid":"https://orcid.org/0000-0003-2609-4896","observed_orcids":["https://orcid.org/0000-0003-2609-4896"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Graciela Andrei","raw_affiliation_strings":["Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000, Leuven, Belgium. graciela.andrei@rega.kuleuven.ac.be","Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000, Leuven, Belgium. graciela.andrei@rega.kuleuven.ac.be","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085228034","display_name":"Robert Snoeck","orcid":"https://orcid.org/0000-0002-7586-5434","observed_orcids":["https://orcid.org/0000-0002-7586-5434"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Robert Snoeck","raw_affiliation_strings":["Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089010495","display_name":"Johan H. Neyts","orcid":"https://orcid.org/0000-0002-0033-7514","observed_orcids":["https://orcid.org/0000-0002-0033-7514"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Johan Neyts","raw_affiliation_strings":["Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060723543","display_name":"Marit Liland Sandvold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132748","display_name":"Norsk Hydro (Norway)","ror":"https://ror.org/03vx93323","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210132748"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Marit Liland Sandvold","raw_affiliation_strings":["Norsk Hydro ASA, N-3907 Porsgrunn, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norsk Hydro ASA, N-3907 Porsgrunn, Norway","institution_ids":["https://openalex.org/I4210132748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018573283","display_name":"Finn Myhren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132748","display_name":"Norsk Hydro (Norway)","ror":"https://ror.org/03vx93323","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210132748"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Finn Myhren","raw_affiliation_strings":["Norsk Hydro ASA, N-3907 Porsgrunn, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norsk Hydro ASA, N-3907 Porsgrunn, Norway","institution_ids":["https://openalex.org/I4210132748"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040662398","display_name":"Erik De Clercq","orcid":"https://orcid.org/0000-0002-2985-8890","observed_orcids":["https://orcid.org/0000-0002-2985-8890"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Erik De Clercq","raw_affiliation_strings":["Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Minderbroedersstraat 10, K.U. Leuven, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5030479730"],"corresponding_institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":null,"fwci":1.3376,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.80240031,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"45","issue":"3","first_page":"157","last_page":"167"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ganciclovir","display_name":"ganciclovir","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-1","display_name":"herpes simplex virus type 1","score":0.9419999718666077},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-2","display_name":"herpes simplex virus type 2","score":1.0},{"id":"https://openalex.org/keywords/varicella-zoster-virus","display_name":"varicella-zoster virus","score":1.0},{"id":"https://openalex.org/keywords/human-cytomegalovirus","display_name":"human cytomegalovirus","score":0.996999979019165},{"id":"https://openalex.org/keywords/thymidine-kinase-deficiency","display_name":"thymidine kinase deficiency","score":0.8849999904632568},{"id":"https://openalex.org/keywords/foscarnet-resistance","display_name":"foscarnet resistance","score":0.9760000109672546},{"id":"https://openalex.org/keywords/oral-antiviral-therapy","display_name":"oral antiviral therapy","score":0.6759999990463257},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.3790000081062317}],"concepts":[{"id":"https://openalex.org/C2777965375","wikidata":"https://www.wikidata.org/wiki/Q417640","display_name":"Ganciclovir","level":4,"score":0.9374446868896484},{"id":"https://openalex.org/C2776147627","wikidata":"https://www.wikidata.org/wiki/Q24783855","display_name":"Thymidine kinase","level":4,"score":0.6856210231781006},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.6413885951042175},{"id":"https://openalex.org/C2776824251","wikidata":"https://www.wikidata.org/wiki/Q423445","display_name":"Cidofovir","level":3,"score":0.6173956990242004},{"id":"https://openalex.org/C2776724271","wikidata":"https://www.wikidata.org/wiki/Q420387","display_name":"Foscarnet","level":5,"score":0.5093949437141418},{"id":"https://openalex.org/C2779820661","wikidata":"https://www.wikidata.org/wiki/Q6929","display_name":"Human cytomegalovirus","level":3,"score":0.5092931985855103},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.47933682799339294},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3975943624973297},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36476054787635803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35988467931747437},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27126356959342957},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.26870524883270264},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001973","descriptor_name":"Bromodeoxyuridine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001973","descriptor_name":"Bromodeoxyuridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014645","descriptor_name":"Herpesvirus 3, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015774","descriptor_name":"Ganciclovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015774","descriptor_name":"Ganciclovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015774","descriptor_name":"Ganciclovir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017245","descriptor_name":"Foscarnet","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018139","descriptor_name":"Simplexvirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0166-3542(00)00070-x","doi":"https://doi.org/10.1016/s0166-3542(00)00070-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0166-3542(00)00070-x","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},{"id":"pmid:10771080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10771080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W584325581","https://openalex.org/W1508738567","https://openalex.org/W1526530838","https://openalex.org/W1590621449","https://openalex.org/W1599727599","https://openalex.org/W1791027840","https://openalex.org/W1802007569","https://openalex.org/W1824308746","https://openalex.org/W1909341276","https://openalex.org/W1971641536","https://openalex.org/W1976379944","https://openalex.org/W1978618775","https://openalex.org/W1979266082","https://openalex.org/W1980506911","https://openalex.org/W1983120156","https://openalex.org/W1988428680","https://openalex.org/W1989995292","https://openalex.org/W1992933258","https://openalex.org/W2002040141","https://openalex.org/W2002553384","https://openalex.org/W2003370236","https://openalex.org/W2010462587","https://openalex.org/W2015772291","https://openalex.org/W2016138321","https://openalex.org/W2028273426","https://openalex.org/W2050612845","https://openalex.org/W2054092356","https://openalex.org/W2061021155","https://openalex.org/W2062023486","https://openalex.org/W2062170716","https://openalex.org/W2071003885","https://openalex.org/W2090222270","https://openalex.org/W2113209260","https://openalex.org/W2122681725","https://openalex.org/W2130166897","https://openalex.org/W2136652714","https://openalex.org/W2326800093","https://openalex.org/W2342812949","https://openalex.org/W4231692149","https://openalex.org/W4252017411","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2028426337","https://openalex.org/W2018008813","https://openalex.org/W1983120156","https://openalex.org/W2902044614","https://openalex.org/W3120589563","https://openalex.org/W1590621449","https://openalex.org/W2354949758","https://openalex.org/W2152511800","https://openalex.org/W3208182620","https://openalex.org/W3016915813"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}